who should not use a glp 1 Why I'm Choosing to Take GLP-1s, Even Though Everyone Expects Me To GLP-1 nausea: How to handle

FDA Approval Status: Approved: September 2019 Indication: Type 2 diabetes management NOT approved for weight loss specifically Manufacturer: Novo Nordisk Available Doses: 3 mg (starting dose) 7 mg (maintenance dose) 14 mg (maximum dose) How Rybelsus Works: SNAC Technology: Rybelsus uses a compound called SNAC (salcaprozate sodium) to help semaglutide absorb through the stomach lining

Wang, A., Shi, W., Zhang, N., Tang, H

Six months into the green list era In September 2025, the FDA launched an import enforcement framework targeting foreign-sourced weight loss active pharmaceutical ingredients used in compounding

A Cochrane Review summary with commentary

GLP-1 RAs in combination with metformin showed even more weight loss and improvement in markers of hyperandrogenism

Nausea, diarrhea, and vomiting were the most common complaints, occurring primarily during dose escalation periods